IL-17 signaling in host defense and inflammatory diseases

Cellular and Molecular Immunology

Volumn 7, Issue 5, 2010, Pages 328-333

  Qian, Youcun ^a   Kang, Zizhen ^b   Liu, Caini ^b   Li, Xiaoxia ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

inflammation; interleukin 17; signaling

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 17B; INTERLEUKIN 17C; INTERLEUKIN 17F; INTERLEUKIN 25; INTERLEUKIN 27; JANUS KINASE; MESSENGER RNA; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; B LYMPHOCYTE; BACTERIAL INFECTION; BINDING AFFINITY; GENE EXPRESSION; GENE INDUCTION; GENE TARGETING; HOST RESISTANCE; HUMAN; INFLAMMATORY DISEASE; LEUKOCYTE ACTIVATION; MYCOSIS; NONHUMAN; PARASITOSIS; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH17 CELL; ANIMAL; IMMUNOLOGY; INFLAMMATION; METABOLISM;

BACTERIA (MICROORGANISMS);

ANIMALS; AUTOIMMUNE DISEASES; HUMANS; INFLAMMATION; INTERLEUKIN-17; RECEPTORS, INTERLEUKIN-17; SIGNAL TRANSDUCTION;

EID: 77957656741     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2010.27     Document Type: Review

References (70)

1. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 145-173. (Pubitemid 19138011)
2. Glimcher LH, Murphy KM. Lineage commitment in the immune system: the T helper lymphocyte grows up. Genes Dev 2000; 14: 1693-1711. (Pubitemid 30602989)
3. Krakowski M, Owens T. Interferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur J Immunol 1996; 26: 1641-1646. (Pubitemid 26230015)
4. Gran B, Zhang GX, Yu S, Li J, Chen XH, Ventura ES et al. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J Immunol 2002; 169: 7104-7110. (Pubitemid 36899299)
5. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu Rev Immunol 2009; 27: 485-517.
6. Stromnes IM, Cerretti LM, Liggitt D, Harris RA, Goverman JM. Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat Med 2008; 14: 337-342. (Pubitemid 351347910)
7. Jager A, Dardalhon V, Sobel RA, Bettelli E, Kuchroo VK. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J Immunol 2009; 183: 7169-7177.
8. O'Connor RA, Prendergast CT, Sabatos CA, Lau CW, Leech MD, Wraith DC et al. Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J Immunol 2008; 181: 3750-3754.
9. Axtell RC, Jong BA, Boniface K, Voort LF, Bhat R, Sarno P et al. T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat Med 2010; 16: 406-412.
10. O'Shea JJ, Steward-Tharp SM, Laurence A, Watford WT, Wei L, Adamson AS et al. Signal transduction and Th17 cell differentiation. Microbes Infect 2009; 11: 599-611.
11. Dong C. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 2008; 8: 337-348. (Pubitemid 351595217)
12. Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009; 361: 888-898.
13. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008; 28: 454-467. (Pubitemid 351471762)
14. Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007; 25: 821-852. (Pubitemid 46697925)
15. Weaver CT, Hatton RD. Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective. Nat Rev Immunol 2009; 9: 883-889.
16. Gaffen SL. Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 2009; 9: 556-567.
17. Hymowitz SG, Filvaroff EH, Yin JP, Lee J, Cai L, Risser P et al. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J 2001; 20: 5332-5341.
18. Chang SH, Dong C. IL-17F: regulation, signaling and function in inflammation. Cytokine 2009; 46: 7-11.
19. Wright JF, Bennett F, Li B, Brooks J, Luxenberg DP, Whitters MJ et al. The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex. J Immunol 2008; 181: 2799-2805.
20. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 2004; 21: 467-476. (Pubitemid 39370503)
21. Moseley TA, Haudenschild DR, Rose L, Reddi AH. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 2003; 14: 155-174. (Pubitemid 36389528)
22. Wang YH, Liu YJ. The IL-17 cytokine family and their role in allergic inflammation. Curr Opin Immunol 2008; 20: 697-702.
23. Ely LK, Fischer S, Garcia KC. Structural basis of receptor sharing by interleukin 17 cytokines. Nat Immunol 2009; 10: 1245-1251.
24. Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 2001; 194: 519-527. (Pubitemid 32835046)
25. Happel KI, Dubin PJ, Zheng M, Ghilardi N, Lockhart C, Quinton LJ et al. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J Exp Med 2005; 202: 761-769. (Pubitemid 41345965)
26. Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 2009; 206: 299-311.
27. Huang W, Na L, Fidel PL, Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 2004; 190: 624-631. (Pubitemid 38982105)
28. Kelly MN, Kolls JK, Happel K, Schwartzman JD, Schwarzenberger P, Combe C et al. Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infect Immun 2005; 73: 617-621. (Pubitemid 40041158)
29. Lin Y, Ritchea S, Logar A, Slight S, Messmer M, Rangel-Moreno J et al. Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity 2009; 31: 799-810.
30. Crowe CR, Chen K, Pociask DA, Alcorn JF, Krivich C, Enelow RI et al. Critical role of IL-17RA in immunopathology of influenza infection. J Immunol 2009; 183: 5301-5310.
31. Wiehler S, Proud D. Interleukin-17A modulates human airway epithelial responses to human rhinovirus infection. Am J Physiol Lung Cell Mol Physiol 2007; 293: L505-L515. (Pubitemid 47205032)
32. Grigorian A, Torossian S, Demetriou M. T-cell growth, cell surface organization, and the galectin-glycoprotein lattice. Immunol Rev 2009; 230: 232-246.
33. Green DR, Ferguson T, Zitvogel L, Kroemer G. Immunogenic and tolerogenic cell death. Nat Rev Immunol 2009; 9: 353-363.
34. Koenders MI, Kolls JK, Oppers-Walgreen B, van den Bersselaar L, Joosten LA, Schurr JR et al. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis. Arthritis Rheum 2005; 52: 3239-3247.
35. Yu JJ, Ruddy MJ, Wong GC, Sfintescu C, Baker PJ, Smith JB et al. An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood 2007; 109: 3794-3802. (Pubitemid 46641730)
36. Gonzalez-Garcia I, Zhao Y, Ju S, Gu Q, Liu L, Kolls JK et al. IL-17 signaling-independent central nervous system autoimmunity is negatively regulated by TGF-beta. J Immunol 2009; 182: 2665-2671.
37. Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, Kakuta S et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 2006; 177: 566-573. (Pubitemid 43939170)
38. Burchill MA, Nardelli DT, England DM, DeCoster DJ, Christopherson JA, Callister SM et al. Inhibition of interleukin-17 prevents the development of arthritis in vaccinated mice challenged with Borrelia burgdorferi. Infect Immun 2003; 71: 3437-3442. (Pubitemid 36637572)
39. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6: 1133-1141. (Pubitemid 41541791)
40. Wang L, Yi T, Kortylewski M, Pardoll DM, Zeng D, Yu H. IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med 2009; 206: 1457-1464.
41. Kryczek I, Wei S, Szeliga W, Vatan L, Zou W. Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood 2009; 114: 357-359.
42. Schwandner R, Yamaguchi K, Cao Z. Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction. J Exp Med 2000; 191: 1233-1240.
43. Novatchkova M, Leibbrandt A, Werzowa J, Neubuser A, Eisenhaber F. The STIR-domain superfamily in signal transduction, development and immunity. Trends Biochem Sci 2003; 28: 226-229. (Pubitemid 36588662)
44. Chang SH, Park H, Dong C. Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor. J Biol Chem 2006; 281: 35603-35607. (Pubitemid 46041290)
45. Qian Y, Qin J, Cui G, Naramura M, Snow EC, Ware CF et al. Act1, a negative regulator in CD40- and BAFF-mediated B cell survival. Immunity 2004; 21: 575-587. (Pubitemid 39370512)
46. Qian Y, Giltiay N, Xiao J, Wang Y, Tian J, Han S et al. Deficiency of Act1, a critical modulator of B cell function, leads to development of Sjögren's syndrome. Eur J Immunol 2008; 38: 2219-2228.
47. Qian Y, Liu C, Hartupee J, Altuntas CZ, Gulen MF, Jane-Wit D et al. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat Immunol 2007; 8: 247-256.
48. Levin SD. IL-17 receptor signaling: ubiquitin gets in on the act. Sci Signal 2009; 2: pe64.
49. Liu C, Qian W, Qian Y, Giltiay NV, Lu Y, Swaidani S, et al. Act1, a U-box E3 ubiquitin ligase for IL-17 signaling. Sci Signal 2009; 2: ra63.
50. Huang F, Kao CY, Wachi S, Thai P, Ryu J, Wu R. Requirement for both JAK-mediated PI3K signaling and ACT1/TRAF6/TAK1-dependent NF-kappaB activation by IL-17A in enhancing cytokine expression in human airway epithelial cells. J Immunol 2007; 179: 6504-6513.
51. Saleh A, Shan L, Halayko AJ, Kung S, Gounni AS. Critical role for STAT3 in IL-17A-mediated CCL11 expression in human airway smooth muscle cells. J Immunol 2009; 182: 3357-3365.
52. Hartupee J, Liu C, Novotny M, Sun D, Li X, Hamilton TA. IL-17 signaling for mRNA stabilization does not require TNF receptor-associated factor 6. J Immunol 2009; 182: 1660-1666.
53. Lindemann MJ, Hu Z, Benczik M, Liu KD, Gaffen SL. Differential regulation of the IL-17 receptor by gammac cytokines: inhibitory signaling by the phosphatidylinositol 3-kinase pathway. J Biol Chem 2008; 283: 14100-14108.
54. Shen F, Li N, Gade P, Kalvakolanu DV, Weibley T, Doble B et al. IL-17 receptor signaling inhibits C/EBPbeta by sequential phosphorylation of the regulatory 2 domain. Sci Signal 2009; 2: ra8.
55. Hurst SD, Muchamuel T, Gorman DM, Gilbert JM, Clifford T, Kwan S et al. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J Immunol 2002; 169: 443-453. (Pubitemid 34686166)
56. Wang YH, Angkasekwinai P, Lu N, Voo KS, Arima K, Hanabuchi S et al. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J Exp Med 2007; 204: 1837-1847. (Pubitemid 47236321)
57. Angkasekwinai P, Park H, Wang YH, Chang SH, Corry DB, Liu YJ et al. Interleukin 25 promotes the initiation of proallergic type 2 responses. J Exp Med 2007; 204: 1509-1517. (Pubitemid 47048018)
58. Fallon PG, Ballantyne SJ, Mangan NE, Barlow JL, Dasvarma A, Hewett DR et al. Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J Exp Med 2006; 203: 1105-1116.
59. Owyang AM, Zaph C, Wilson EH, Guild KJ, McClanahan T, Miller HR et al. Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract. J Exp Med 2006; 203: 843-849.
60. Maezawa Y, Nakajima H, Suzuki K, Tamachi T, Ikeda K, Inoue J et al. Involvement of TNF receptor-associated factor 6 in IL-25 receptor signaling. J Immunol 2006; 176: 1013-1018. (Pubitemid 43099701)
61. Rickel EA, Siegel LA, Yoon BR, Rottman JB, Kugler DG, Swart DA et al. Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities. J Immunol 2008; 181: 4299-4310.
62. Swaidani S, Bulek K, Kang Z, Liu C, Lu Y, Yin W et al. The critical role of epithelial-derived Act1 in IL-17- and IL-25-mediated pulmonary inflammation. J Immunol 2009; 182: 1631-1640.
63. Claudio E, Sonder SU, Saret S, Carvalho G, Ramalingam TR, Wynn TA et al. The adaptor protein CIKS/Act1 is essential for IL-25-mediated allergic airway inflammation. J Immunol 2009; 182: 1617-1630.
64. Rong Z, Wang A, Li Z, Ren Y, Cheng L, Li Y et al. IL-17RD (Sef or IL-17RLM) interacts with IL-17 receptor and mediates IL-17 signaling. Cell Res 2009; 19: 208-215.
65. Li TS, Li XN, Chang ZJ, Fu XY, Liu L. Identification and functional characterization of a novel interleukin 17 receptor: a possible mitogenic activation through ras/mitogen-activated protein kinase signaling pathway. Cell Signal 2006; 18: 1287-1298. (Pubitemid 43674047)
66. Kang Z, Altuntas CZ, Gulen MF, Liu C, Giltiay N, Qin H et al. Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis. Immunity 2010; 32: 414-425.
67. Zhang Z, Zheng M, Bindas J, Schwarzenberger P, Kolls JK. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm Bowel Dis 2006; 12: 382-388.
68. Ito R, Kita M, Shin-Ya M, Kishida T, Urano A, Takada R et al. Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice. Biochem Biophys Res Commun 2008; 377: 12-16.
69. O'Connor W Jr, Kamanaka M, Booth CJ, Town T, Nakae S, Iwakura Y et al. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol 2009; 10: 603-609.
70. Awasthi A, Kuchroo VK. IL-17A directly inhibits TH1 cells and thereby suppresses development of intestinal inflammation. Nat Immunol 2009; 10: 568-570.